Several makers of hepatitis C drugs are limiting health care providers’ access to the 340B Drug Pricing Program’s discounts.
Powered by WPeMatico
Hepatitis and HIV Groups Protest 340B Restrictions to Low-Cost Drugs
%d bloggers like this: